Tumor Microenvironment Targeted Nanotherapy

Bibliographic Details
Title: Tumor Microenvironment Targeted Nanotherapy
Authors: Clara Fernandes, Divya Suares, Mayur C Yergeri
Source: Frontiers in Pharmacology, Vol 9 (2018)
Publisher Information: Frontiers Media S.A., 2018.
Publication Year: 2018
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: tumor microenviroment, cancer, nano therapy, nano carrier, resistance, Therapeutics. Pharmacology, RM1-950
More Details: Recent developments in nanotechnology have brought new approaches to cancer diagnosis and therapy. While enhanced permeability and retention effect promotes nano-chemotherapeutics extravasation, the abnormal tumor vasculature, high interstitial pressure and dense stroma structure limit homogeneous intratumoral distribution of nano-chemotherapeutics and compromise their imaging and therapeutic effect. Moreover, heterogeneous distribution of nano-chemotherapeutics in non-tumor-stroma cells damages the non-tumor cells, and interferes with tumor-stroma crosstalk. This can lead not only to inhibition of tumor progression, but can also paradoxically induce acquired resistance and facilitate tumor cell proliferation and metastasis. Overall, the tumor microenvironment plays a vital role in regulating nano-chemotherapeutics distribution and their biological effects. In this review, the barriers in tumor microenvironment, its consequential effects on nano-chemotherapeutics, considerations to improve nano-chemotherapeutics delivery and combinatory strategies to overcome acquired resistance induced by tumor microenvironment have been summarized. The various strategies viz., nanotechnology based approach as well as ligand-mediated, redox-responsive, and enzyme-mediated based combinatorial nanoapproaches have been discussed in this review.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1663-9812
Relation: https://www.frontiersin.org/article/10.3389/fphar.2018.01230/full; https://doaj.org/toc/1663-9812
DOI: 10.3389/fphar.2018.01230
Access URL: https://doaj.org/article/f4a23b9dc0a5460492c72e16fbb21d95
Accession Number: edsdoj.f4a23b9dc0a5460492c72e16fbb21d95
Database: Directory of Open Access Journals
More Details
ISSN:16639812
DOI:10.3389/fphar.2018.01230
Published in:Frontiers in Pharmacology
Language:English